AHR GENE METHYLATION AND PROTEIN EXPRESSION IN DIFFERENT MALIGNANCY GLIOMAS

Indrė Valiulytė1, 2, Mykolas Mikučiūnas1, 3, Paulina Vaitkienė1, Daina Skiriutė1, Arūnas Kazlauskas1

1 Laboratory of Neurooncology and Genetics, Institute of Neuroscience, Kaunas Academy of Medicine, Lithuanian University of Health Sciences, Eiveniu str. 4, Kaunas, LT 50009, Lithuania

2 Department of Biochemistry and Biotechnologies, The Faculty of Natural Sciences, Vytautas Magnus University, Kaunas, Lithuania. Vileikos str. 8, LT-44404 Kaunas

3 The Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania, A. Mickevičiaus str.9.

Glioblastoma is highly aggressive primary brain tumor with strongly variable patient survival. The AhR gene methylation is one of several potential epigenetic prognostic markers in glioblastoma. AhR gene expression is involved in many critical life processes (e.g. cell type-specific differentiation, cell division, apoptosis).

The objective of this study was to investigate AhR gene methylation and protein expression in human brain tumor – glioma.

Methods: Were investigated 73 patients with different grade gliomas: grade I- 8 samples, grade II – 8, grade III - 8 and grade IV (Glioblastoma) – 48 samples. Tumor DNA was extracted from 25-40mg of frozen tissue and the methylation status of AhR gene promoter was determined by bisulfite treatment of DNA. AhR gene methylation was performed by using methylation specific polymerase chain reaction (MS-PCR) method. MS- PCR products were separated by electrophoresis on 2% agarose gels with ethidium bromide and visualized under UV illumination. Western blot was used to determine the AhR expression in gliomas.

Results: 37.5% of all patients had AhR gene methylation. In diffrerent malignancy grade gliomas AhR gene promother methylation frequencys were varied. Glioblastomas demonstrated AhR promother methylation in 25/48 (52.1%). All of grade I (0/8) and grade III (0/8) gliomas have not showed AhR promoter methylation. AhR promoter methylation was observed in 25% (2/8) of grade II gliomas. AhR protein expression was different between glioma malignancy grades.

In conclusion: AhR gene methylation is related with glioma malignancy. AhR gene methylation may be involved in gliomagenis process and might be one of the potential epigenetic prognostic markers in glioblastoma.

Acknowledgments: This research was funded by a grant (No. LIG-11/2012) from the Research Council of Lithuania.